Our portfolio reflects our belief in backing bold founders and advancing technologies critical to national security—with real traction and lasting impact.
Our portfolio reflects our belief in backing bold founders and advancing technologies critical to national security—with real traction and lasting impact.
CHO Plus is a biotechnology company that develops patented engineered mammalian cell lines to dramatically increase therapeutic protein and virus production for biopharmaceutical manufacturers, lowering costs and boosting manufacturing capacity through licensing and strategic partnerships.
The Leonid Capital Partners Investor Portal offers secure, real-time access to investment insights, portfolio performance, and key documents, ensuring transparency and ease of management.
